Free Trial

Genetic Technologies (GENE) News Today

Genetic Technologies logo
$0.76 0.00 (0.00%)
(As of 11/14/2024 ET)
Genetic Technologies Extends Voluntary Suspension for Strategic Moves
Science Is Closing in on a New Way to Treat Pain
Nanoscope Therapeutics Licenses Optogenetic CatCh Technology
Get Genetic Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter.

Elon Musk has put himself in their crosshairs (Ad)

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

GENE Media Mentions By Week

GENE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GENE
News Sentiment

-0.11

0.54

Average
Medical
News Sentiment

GENE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GENE Articles
This Week

7

3

GENE Articles
Average Week

Get Genetic Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GENE) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners